文献速递青光眼神经眼科

比较视网膜神经纤维层与神经节细胞内丛状层OCT变化检测青光眼进展的效用

Comparing the Utility of Retinal Nerve Fiber Layer and Ganglion Cell Inner Plexiform Layer OCT Changes to Detect Glaucoma Progression.
PubMed 文献 · Ophthalmology · 2025-08-11

这项回顾性纵向研究纳入2464只眼(1605例患者),比较进展眼与非进展眼在广泛疾病严重度范围内环视盘视网膜神经纤维层(cpRNFL)和黄斑神经节细胞-内丛状层(mGCIPL)的变薄速率。结果显示进展眼cpRNFL和mGCIPL变薄速率均显著快于非进展眼,两者对视野进展概率的影响总体相似,但cpRNFL在早期青光眼关联更强而mGCIPL在晚期更强。作者结论认为两者依疾病阶段发挥互补作用。

要点

  • 进展眼cpRNFL变薄-1.02 μm/年、mGCIPL变薄-1.04 μm/年,均快于非进展眼的-0.41和-0.41 μm/年。
  • cpRNFL与mGCIPL变薄对视野进展概率的影响总体相似(每快1 μm/年分别增加2.4% vs 2.1%)。
  • cpRNFL在疑似青光眼效应最大而晚期无统计学显著,mGCIPL在疑似最小、随严重度增加且晚期仍有统计学显著。

核心结论

  • cpRNFL与mGCIPL变化依疾病严重度阶段在监测青光眼进展中发挥互补作用。
  • 早期青光眼中cpRNFL与视野进展的关联强于mGCIPL。
  • 晚期青光眼中mGCIPL与进展的关联强于cpRNFL。

研究设计与样本

  • 回顾性纵向研究,纳入2464只眼(1605例患者),均有纵向检测(≥5次可靠cpRNFL、mGCIPL和视野测量)。
  • 所有cpRNFL和mGCIPL测量均在视野检查1年内完成。
  • 采用线性回归测量疑似、轻度、中度及晚期青光眼(严重度按Hodapp-Parrish-Anderson标准定义)的cpRNFL和mGCIPL变薄速率。
  • 采用logistic混合效应模型估计cpRNFL和mGCIPL变薄速率对视野进展概率的影响,并用一般线性假设检验评估各严重度阶段的效应。

主要发现

  • 进展眼cpRNFL变薄速率为-1.02 μm/年、mGCIPL为-1.04 μm/年,非进展眼分别为-0.41和-0.41 μm/年,进展眼显著更快。
  • 进展眼与非进展眼之间的差异随疾病严重度加重而减小。
  • cpRNFL和mGCIPL变薄对视野进展概率的效应总体相似(每1 μm/年更快的变薄速率分别增加2.4% vs 2.1%的概率),但依青光眼严重度不同而异。
  • cpRNFL变薄的效应在疑似青光眼中最大,在晚期青光眼中无统计学显著。
  • mGCIPL变薄的效应在疑似青光眼中最小,随疾病严重度加重而增加,在晚期疾病中仍有统计学显著。

关键数值与推荐

  • 进展眼cpRNFL变薄-1.02 μm/年 vs 非进展眼-0.41 μm/年。
  • 进展眼mGCIPL变薄-1.04 μm/年 vs 非进展眼-0.41 μm/年。
  • 每1 μm/年更快的cpRNFL变薄速率对应视野进展概率增加2.4%。
  • 每1 μm/年更快的mGCIPL变薄速率对应视野进展概率增加2.1%。
  • 疾病严重度按Hodapp-Parrish-Anderson标准分为疑似、轻度、中度、晚期。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Measure and compare the rates of circumpapillary retinal nerve fiber layer (cpRNFL) and macular ganglion cell-inner plexiform layer (mGCIPL) thinning in glaucomatous eyes with and without visual field (VF) progression, across a broad range of disease severity, in a large clinical population. DESIGN: Retrospective, longitudinal study. PARTICIPANTS: A total of 2464 eyes (1605 patients) with longitudinal testing (≥5 reliable cpRNFL, mGCIPL, and VF measurements). All cpRNFL and mGCIPL measurements were within 1 year of a VF test. METHODS: We used linear regression to measure rates of cpRNFL and mGCIPL thinning in suspect, mild, moderate, and advanced glaucoma (severity defined by Hodapp-Parrish-Anderson criteria). We compared thinning rates between eyes with and without VF progression (using trend- or event-based criteria). Next, we used logistic mixed-effects models to estimate the impact of cpRNFL and mGCIPL thinning rates on the probability of VF progression. We used general linear hypothesis testing to assess the effect of cpRNFL and mGCIPL thinning rates in each stage of severity. MAIN OUTCOME MEASURES: Rates of cpRNFL and mGCIPL thinning (μm/year) stratified by disease severity. RESULTS: The cpRNFL and mGCIPL thinning rates were significantly faster in progressing eyes (-1.02 and -1.04 μm/year, respectively) than in nonprogressing eyes (-0.41 and -0.41 μm/year, respectively). Differences between progressors and nonprogressors diminished with worsening disease severity. The effect of cpRNFL and mGCIPL thinning on the probability of VF progression was similar overall (2.4% vs. 2.1% increased probability per 1 μm/year faster rate of thinning) but differed depending on the glaucoma severity. The effect of cpRNFL thinning was greatest in glaucoma suspects but was not statistically significant in advanced glaucoma. In contrast, the effect of mGCIPL thinning was smallest in suspects, increased with worsening disease severity, and was still statistically significant in advanced disease. CONCLUSIONS: The cpRNFL and mGCIPL changes serve complementary roles in monitoring glaucoma progression depending on the stage of disease severity. The cpRNFL is more strongly associated with VF progression than mGCIPL in early glaucoma. The mGCIPL is more strongly associated with progression than cpRNFL in later stages of glaucoma. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Pham AT, Bradley C, Yohannan J, et al. Comparing the Utility of Retinal Nerve Fiber Layer and Ganglion Cell Inner Plexiform Layer OCT Changes to Detect Glaucoma Progression. Ophthalmology. 2025. PMID: 40803537. doi:10.1016/j.ophtha.2025.07.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。